Sevelamer Carbonate
Sevelamer Carbonate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Sevelamer Carbonate; Generic name: SEVELAMER CARBONATE; Manufacturer: ATLANTIC BIOLOGICALS CORP..
| Brand name | Sevelamer Carbonate |
|---|---|
| Generic name | SEVELAMER CARBONATE |
| Manufacturer | ATLANTIC BIOLOGICALS CORP. |
| Used for | 1 INDICATIONS AND USAGE Sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults with chronic kidney disease (CKD) on dialysis. Pediatric use information is approved for Genzyme Corporation’s Renvela (sevelamer carbonate) tablets and Renvela (sevelamer carbonate) for oral suspension. However, due to Genzyme Corporation’s marketing exclusivity rights, these drug products are not labeled with that pediatric information. Sevelamer carbonate tablets are a phosphate binder indicated for the control of serum phosphorus in adults with chronic kidney disease on dialysis. (1) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Starting dose of sevelamer carbonate tablets is 0.8 or 1.6 grams administered orally three times per day with meals based on serum phosphorus levels for adult patients. ( 2.1 ) Titrate by 0.8 g per meal in two week intervals for adult patients as needed to obtain serum phosphorus target. ( 2.1 ) 2.1 General Dosing Information Starting Dose for Adult Patients Not Taking a Phosphate Binder. The recommended starting dose of sevelamer carbonate tablets is 0.8 to 1.6 g tak |
| Active ingredient(s) | SEVELAMER CARBONATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07b709fd-a2a1-4ff1-ad19-827d38e84562 |